Futura Medical.
49 announcements.
49 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
07:00 | 02-12-2024 | FUM | Futura Medical | Block Listing Six Monthly Return |
07:00 | 15-11-2024 | FUM | Futura Medical | TR-1: Notification of major holdings |
07:00 | 04-11-2024 | FUM | Futura Medical | Encouraging New Product Development Pipeline |
07:00 | 31-10-2024 | FUM | Futura Medical | Total Voting Rights |
07:00 | 07-10-2024 | FUM | Futura Medical | Further milestone payment triggered post US launch |
07:00 | 01-10-2024 | FUM | Futura Medical | Total Voting Rights |
07:00 | 13-09-2024 | FUM | Futura Medical | Directors’ / PDMR Dealing |
17:43 | 11-09-2024 | FUM | Futura Medical | Trinity Delta research note & consensus forecasts |
07:00 | 10-09-2024 | FUM | Futura Medical | Futura Medical - Interim Results 2024 |
10:47 | 02-09-2024 | FUM | Futura Medical | Update on US Launch |
07:00 | 02-09-2024 | FUM | Futura Medical | Update on US launch |
07:00 | 19-08-2024 | FUM | Futura Medical | Notice of Results |
07:05 | 01-08-2024 | FUM | Futura Medical | Update on US launch |
14:13 | 01-07-2024 | FUM | Futura Medical | Total Voting Rights |
07:00 | 01-07-2024 | FUM | Futura Medical | Nominated Adviser and Joint Broker |
16:12 | 20-06-2024 | FUM | Futura Medical | Result of AGM |
07:00 | 20-06-2024 | FUM | Futura Medical | AGM Statement |
07:00 | 31-05-2024 | FUM | Futura Medical | Block Listing Six Monthly Review |
07:00 | 24-05-2024 | FUM | Futura Medical | Notice of AGM and availability of Annual Report |
07:00 | 29-04-2024 | FUM | Futura Medical | Directors’ / PDMR Dealing and Grant of Options |
07:00 | 10-04-2024 | FUM | Futura Medical | Results for the Year ended 31 December 2023 |
07:00 | 25-03-2024 | FUM | Futura Medical | Notice of Results and Investor Presentation |
07:01 | 06-02-2024 | FUM | Futura Medical | Trading Update |
07:00 | 06-02-2024 | FUM | Futura Medical | Appointment of Joint Corporate Broker |
07:00 | 17-01-2024 | FUM | Futura Medical | Director/PDMR Dealing |
07:00 | 17-01-2024 | FUM | Futura Medical | Remuneration of Non-Exec Directors & Voting Rights |
07:00 | 15-01-2024 | FUM | Futura Medical | Futura Medical extends collaboration with Cooper |
07:00 | 09-01-2024 | FUM | Futura Medical | Appointment of Roy Davis as Non-Executive Director |
15:10 | 30-11-2023 | FUM | Futura Medical | Total Voting Rights |
15:10 | 30-11-2023 | FUM | Futura Medical | Block Listing Six Monthly Return |
07:00 | 07-11-2023 | FUM | Futura Medical | Futura expands partnership with M8 Pharmaceuticals |
07:00 | 31-10-2023 | FUM | Futura Medical | Block Listing Application and Total Voting Rights |
07:00 | 10-10-2023 | FUM | Futura Medical | Directors’/PDMR Dealing and Grant of Options |
07:00 | 02-10-2023 | FUM | Futura Medical | European Patent Granted for MED3000 until 2040 |
07:00 | 18-09-2023 | FUM | Futura Medical | Futura Medical - Interim Results 2023 |
07:00 | 18-08-2023 | FUM | Futura Medical | Futura Medical - Notice of Interim Results |
07:00 | 31-07-2023 | FUM | Futura Medical | Futura Medical - Total Voting Rights |
11:04 | 18-07-2023 | FUM | Futura Medical | Board Change |
07:00 | 17-07-2023 | FUM | Futura Medical | Futura/Haleon Enter US Commercialisation Agreement |
07:00 | 30-06-2023 | FUM | Futura Medical | Futura Medical - Total Voting Rights |
15:19 | 22-06-2023 | FUM | Futura Medical | Futura Medical Annual General Meeting Results |
07:00 | 22-06-2023 | FUM | Futura Medical | Futura Medical AGM Statement |
10:25 | 19-06-2023 | FUM | Futura Medical | Correction - TR-1: Notification of major holdings |
16:05 | 16-06-2023 | FUM | Futura Medical | TR-1: Notification of major holdings |
08:23 | 12-06-2023 | FUM | Futura Medical | Exercise of Warrants |
07:00 | 12-06-2023 | FUM | Futura Medical | MED3000 Granted US FDA Approval for OTC Sale |
07:00 | 08-06-2023 | FUM | Futura Medical | Futura Medical Announces Investor Seminar |
07:00 | 31-05-2023 | FUM | Futura Medical | Block Listing Six Monthly Return |
07:00 | 26-05-2023 | FUM | Futura Medical | Notice of AGM and availability of Annual Report |